MR1 and neoplasm: Having verified successful knockout of MR1 on B16F10 tumor cells (Supplementary Fig. 2d), we observed that 5-OP-RU no longer exhibited an anti-tumor effect (Fig. 2f), thus confirming the requirement for tumor-derived MR1 expression in this antigen-pulsing model.